Kent D. Stewart

5.2k citations

91 papers · 3.1k indexed · h-index 34

Co-authors: Akhteruzzaman Molla Dale J. Kempf Hing L. Sham Vincent L. Giranda Eric F. Johnson Cele Abad‐Zapatero Thomas J. Sowin Steven W. Muchmore
Topics: HIV/AIDS drug development and treatment (16 papers)Peptidase Inhibition and Analysis (13 papers)HIV Research and Treatment (12 papers)
Cited by: Virology Hepatology Organic Chemistry
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Physiological Reviews
Partner nations: United States United Kingdom Australia

In The Last Decade

Kent D. Stewart

91 papers receiving 2.9k citations

Peers

Countries citing papers authored by Kent D. Stewart

Since Specialization

Citations

This map shows the geographic impact of Kent D. Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kent D. Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kent D. Stewart more than expected).

Fields of papers citing papers by Kent D. Stewart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kent D. Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kent D. Stewart. The network helps show where Kent D. Stewart may publish in the future.

Co-authorship network of co-authors of Kent D. Stewart

This figure shows the co-authorship network connecting the top 25 collaborators of Kent D. Stewart. A scholar is included among the top collaborators of Kent D. Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kent D. Stewart. Kent D. Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumours 2012 ·European Journal of Cancer ·Iain R. Macpherson,Srinivasu Poondru,George R. Simon,Richard Gedrich,(unknown),C. A. Hopkins,Kent D. Stewart,Andrew Stephens,T.R. Jeffry Evans	10
2	Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families 2012 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin,Robin R. Frey,H. Robin Heyman,Niru B. Soni,Patrick A. Marcotte,Lori J. Pease,Keith B. Glaser,Terrance J. Magoc,Paul Tapang,Daniel H. Albert,Donald J. Osterling,Amanda M. Olson,Jennifer J. Bouska,Zhiwen Guan,Lee C. Preusser,James S. Polakowski,Kent D. Stewart,Chris Tse,Steven K. Davidsen,Michael R. Michaelides	19
3	Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases 2012 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin,H. Robin Heyman,Robin R. Frey,Patrick A. Marcotte,Keith B. Glaser,(unknown),Terrance J. Magoc,Daniel H. Albert,Amanda M. Olson,David R. Reuter,Jennifer J. Bouska,Debra Montgomery,Joann P. Palma,Cherrie K. Donawho,Kent D. Stewart,Chris Tse,Michael R. Michaelides	12
4	Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases 2010 ·Bioorganic & Medicinal Chemistry Letters ·Steve Fidanze,Scott Erickson,Gary T. Wang,Robert A. Mantei,Richard F. Clark,Bryan K. Sorensen,Nwe Y. BaMaung,Peter Kovar,Eric F. Johnson,Kerren K. Swinger,Kent D. Stewart,Qian Zhang,Lora A. Tucker,William N. Pappano,Julie L. Wilsbacher,Jieyi Wang,George S. Sheppard,Randy L. Bell,Steven K. Davidsen,Robert D. Hubbard	50
5	Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: Improving oral biovailability 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yunsong Tong,(unknown),Zhi‐Fu Tao,Jennifer J. Bouska,Kent D. Stewart,Chang Park,Gaoquan Li,Akiyo Claiborne,Peter Kovar,Zehan Chen,Philip J. Merta,(unknown),Amanda M. Olson,Donald J. Osterling,Haiying Zhang,Hing L. Sham,Saul H. Rosenberg,Thomas J. Sowin,Nan‐Horng Lin	5
6	Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yujia Dai,(unknown),Niru B. Soni,Lori J. Pease,David R. Reuter,Amanda M. Olson,Donald J. Osterling,Stella Z. Doktor,Daniel H. Albert,Jennifer J. Bouska,Keith B. Glaser,Patrick A. Marcotte,Kent D. Stewart,Steven K. Davidsen,Michael R. Michaelides	31
7	Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro 2007 ·Antiviral Research ·Liangjun Lu,(unknown),Sherie Masse,Ron Pithawalla,P. Santhana Gopala Krishnan,Wei He,Teresa I. Ng,(unknown),Kent D. Stewart,Daniel P. Larson	29
8	Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jürgen Dinges,Irini Akritopoulou‐Zanze,Lee D. Arnold,Teresa Barlozzari,Peter F. Bousquet,George A. Cunha,Anna Ericsson,(unknown),Michael R. Michaelides,Nobuo Ogawa,(unknown),Paul Rafferty,Thomas J. Sowin,Kent D. Stewart,(unknown),(unknown),(unknown)	19
9	Thienopyridine urea inhibitors of KDR kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·H. Robin Heyman,Robin R. Frey,Peter F. Bousquet,George A. Cunha,Maria D. Moskey,Asma A. Ahmed,Niru B. Soni,Patrick A. Marcotte,Lori J. Pease,Keith B. Glaser,Melinda S. Yates,Jennifer J. Bouska,Daniel H. Albert,(unknown),Peter J. Dandliker,Kent D. Stewart,Paul Rafferty,Steven K. Davidsen,Michael R. Michaelides,Michael L. Curtin	33
10	Drug Guru: A computer software program for drug design using medicinal chemistry rules 2006 ·Bioorganic & Medicinal Chemistry ·Kent D. Stewart,(unknown),Craig A. James	71
11	Establishment and Characterization of 7 New Monoclonal Antibodies to Tissue Inhibitor of Metalloproteinases-1 2005 ·Tumor Biology ·(unknown),Barry L. Dowell,Kent D. Stewart,Vibeke Jensen,Lise Larsen,Ulrik Lademann,Gillian Murphy,Hans Jørgen Nielsen,(unknown),Gerard J. Davis	23
12	Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction 2004 ·Virology ·Hongmei Mo,Alex K. Konstantinidis,Kent D. Stewart,Tatyana Dekhtyar,Teresa I. Ng,Kerry M. Swift,Edmund D. Matayoshi,Warren M. Kati,William E. Kohlbrenner,Akhteruzzaman Molla	38
13	Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Michael Wendt,(unknown),William J. McClellan,Todd W. Rockway,Moshe Weitzberg,(unknown),Robert A. Mantei,Kent D. Stewart,V. Nienaber,Vered Klinghofer,Vincent L. Giranda	24
14	An intramolecular ionic hydrogen bond stabilizes a cis amide bond rotamer of a ring‐opened rapamycin‐degradation product 2004 ·Magnetic Resonance in Chemistry ·(unknown),Kent D. Stewart,Madhup K. Dhaon	11
15	Isoindolinone ureas: a novel class of KDR kinase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin,Robin R. Frey,H. Robin Heyman,Kathy Sarris,Douglas H. Steinman,James H. Holmes,Peter F. Bousquet,George A. Cunha,Maria D. Moskey,Asma A. Ahmed,Lori J. Pease,Keith B. Glaser,Kent D. Stewart,Steven K. Davidsen,Michael R. Michaelides	26
16	Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core 2004 ·Bioorganic & Medicinal Chemistry Letters ·Gary T. Wang,Sheldon Wang,Robert G. Gentles,Thomas J. Sowin,Clarence J. Maring,Dale J. Kempf,Warren M. Kati,Vincent S. Stoll,Kent D. Stewart,Graeme Laver	16
17	Characterization of resistant HIV variants generated by in vitro passage with lopinavir/ritonavir 2003 ·Antiviral Research ·Hongmei Mo,Liangjun Lu,Tatyana Dekhtyar,Kent D. Stewart,Eugene Sun,Dale J. Kempf,Akhteruzzaman Molla	27
18	The 2.2 Å structure of the rRNA methyltransferase ErmC′ and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism 1999 ·Journal of Molecular Biology ·Gerd Schluckebier,Ping Zhong,Kent D. Stewart,(unknown),Cele Abad‐Zapatero	88
19	Diet Design for a Multicenter Controlled Feeding Trial 1998 ·Journal of the American Dietetic Association ·Barbara H. Dennis,Paul W. Stewart,(unknown),Catherine M. Champagne,MARLENE M WINDHAUSER,Abby G. Ershow,Wahida Karmally,Katherine M. Phillips,Kent D. Stewart,(unknown),(unknown),Penny M. Kris‐Etherton	29
20	Symmetry-Based Inhibitors of HIV Protease with Rigid P2 Amino Acid Mimics 1994 ·Protein and Peptide Letters ·Dale J. Kempf,Kent D. Stewart,(unknown),Charles A. Flentge,Norman E. Wideburg,Ayda Saldivar,Sudthida Vasavanonda,Daniel W. Norbeck	2

About Kent D. Stewart

Kent D. Stewart is a scholar working on Virology, Oncology and Organic Chemistry, having authored 91 papers that have together received 3.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), Peptidase Inhibition and Analysis (13 papers) and HIV Research and Treatment (12 papers). The work is most often cited by research in Virology (322 citations), Hepatology (300 citations) and Organic Chemistry (967 citations). Kent D. Stewart has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Akhteruzzaman Molla, Dale J. Kempf, Hing L. Sham, Vincent L. Giranda, Eric F. Johnson, Cele Abad‐Zapatero, Thomas J. Sowin, Steven W. Muchmore, Vincent S. Stoll and Hongmei Mo. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Physiological Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact